Annexon biosciences to present at the bank of america health care conference

Brisbane, calif., may 09, 2024 (globe newswire) -- annexon, inc. (nasdaq: annx), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that douglas love, president and chief executive officer, will present at the bank of america health care conference on tuesday, may 14, 2024 at 8:40 a.m. pt.
ANNX Ratings Summary
ANNX Quant Ranking